Pharmaceutical composition, kit, use of a factor vii preparation or factor vii-related polypeptide in combination with a preparation of a factor ix or factor ix-related polypeptide, use of a composition, method for treating bleeding episodes in a patient , to reduce clotting time in a patient, to intensify hemostasis in a patient, to reduce the number of coagulation factor protein administrations needed to stop bleeding and maintain hemostasis in a patient, to reduce the amount of protein of the administered clotting factor needed to halt bleeding and maintain a patient's hemostasis, to prolong clot lysis time in a patient, to increase clot resistance in a patient, and to intensify fibrin clot formation in a patient. a patient

摘要

"PHARMACEUTICAL COMPOSITION, KIT, USE OF FACTOR VII PREPARATION OR FACTOR VII-RELATED POLYPEPTIDE IN COMBINATION WITH FACTOR IX PREPARATION OR USE OF A FACTOR IX-RELATED POLYPETIDE, USE OF A COMPOSITION, METHOD OF A TRADEMARI METHOD PATIENT, TO REDUCE COAGULATION TIME IN A PATIENT, TO INCREASE HEMOSTASIA IN A PATIENT, TO REDUCE THE NUMBER OF COAGULATION FACTOR PROTECTION NECESSARY TO HOLD HEMORRAGIA ATERIAL AND HEMOSTRAGE IN A PATIENT ADMINISTRATIVE COAGULATION FACTOR PROTEIN NECESSARY TO DETERMINE HEMORRAGY AND MAINTAIN HEMOSTASIA IN A PATIENT, TO ENLARGE THE TIME OF COAGULIS LISM IN A PATIENT, TO INCREASE THE COGULES RESISTANCE IN A PATIENTAL AND FORATIAUS PATIENTS IN A PATIENT ". The invention relates to a pharmaceutical preparation comprising a factor VII or factor VII-related polypeptide, a factor IX or factor IX-related polypeptide. The invention also relates to the use of a factor VII or factor VII-related polypeptide and a factor IX or factor IX-related polypeptide for the manufacture of a medicament for pharmaceutical use, as well as methods for the prevention or treatment of bleeding episodes in patients.